access to the global fund funding update€¦ · • tors and membership of trp - published...
TRANSCRIPT
Access to The Global Fund FundingUpdate
September 2016Geneva, Switzerland
Funding Cycle
REVIEW
GRANT-MAKING
APPROVAL
FUNDIN
G APPLIC
ATIO
N
GRANT IMPLEMENTATION
ONGOING COUNTRY DIALOGUE
APPLICATION
PROCESS
TECH
NIC
AL C
OO
PERA
TIO
N A
ND
REP
ROGR
AMM
ING N
EEDED
NATIONAL STRATEGIES
PRO
GR
AM
REV
IEW APPLICATION PROCESS:
6-9 MONTHS
GRANT IMPLEMENTATION:3 YEARS
Differentiated application and review modalities: agreed with Strategy Committee
2
• Country components requiring material change in defined programmatic area(s); or• Country components receiving Transition Funding or otherwise using a transition work plan as basis for their funding
request; or• Challenging operating environments (COE) country components with material change; or• Innovative approaches, learning opportunities (NSP) or results - based financing modalities (RBF)
Tailored Review: tailored to the objective and to the applicant type
• Focused and Core country components with less than 2 years of implementation (High Impact considered on case - by - case basis ); or
• Focused and Core country components with demonstrated performance and no material change needed (High Impact considered on case -by - case basis); or
Note: To maximize impact against the diseases, program continuation components may in addition reprogram at any time (duringgrant-making or grant implementation) & OPN on reprogramming will apply.
Program continuation: streamlined process for program continuation
• High Impact country components• Focused and Core country components referred to full review • Country components not reviewed by the TRP in the previous allocation period
Full Review: comprehensive overall review of investment approach and strategic priorities
3
ProgramContinuation:a) Secretariat screeningb) CCM request (Feb)c) TRP validation(window 1 only)
Re-programming
NSP
COE
Transition
Innovativeapproaches
Full proposal TRP fullreview
Grant making
TRP tailoredreview
GAC+ Board
Implementation(reprogramming can berequested at any time)
Communication toolbox
• 2017 Eligibility List + Transition projections - published October
• Access to Funding Operational Policy Note - published October
• TORs and membership of TRP - published November
• Application materials - published December
• Information Notes - published December
• Allocation letters - sent December
• FAQ updates published as monthly digest: mid-Sept, mid-Oct, mid-Nov, mid-Dec
• New e-learning courses on: differentiated application process, sustainable transition,
human rights, key populations - January
• Applicant Guide using best practice examples - January
4
Webinars: Train the trainer sessions for GF partners• Each topic offered twice on the same day to allow for different time zones• Invites will be sent out two weeks in advance with confirmed topic
5
Draft schedule
18 + 26 October Differentiated application process: overview to funding cycle
25 October Co-financing for 2017 - 2019 cycle
1 November Updated CCM eligibility and country dialogue guidance
8 November Sustainable transition funding application expectations for transition applicants
15 November Human rights and gender equality in funding requests
22 November Resilient and sustainable systems for health in funding requests
29 November Challenging operating environments applicants
6 + 7 December Allocation key messages and catalytic investments operationalization
13 + 14 December Application materials and resources
17 January TRP review approach and review criteria
24 January Multi-country (Regionals)
Timeline: coming up next
6
September October November December January February March
Key events
Finance andStrategy
CommitteeMeetings
BoardMeeting
AllocationLetters Sent
Tentative: 1 st
SubmissionTentative: 1 st
TRP Meeting
Internalpreparation
QualitativeFactors
Application +ReviewStream
Approval
On-goingSupport toApplicants
ApplicationMaterialsPublished
Eligibility ListPublished
7
If no materialchange
If materialchange
1. Secretariat assessment;2. Applicant (CCM) assessment; Program continuationTRP
validation
Info for material change assessment : 1. Allocation and funding landscape2. Results / Performance3. Epidemiology contextual considerations4. Investing to maximize impact towards
ending the epidemics, noting scientific evidence or normative guidance, new technologies
5. Effectiveness of implementation approaches
6. Risk mitigation considerations7. Progress on TRP/GAC and Board
recommendations8. Ensuring RSSH and HRG9. Sustainability, Transition & Co -financing
Tailored review
Full review
1
2
3
Check-list: material change triggers for program continuation (1/2)
8
Allocation and funding landscape
Results and performance(programmatic and financial)
Risk considerations
Progress on TRP/GAC and Boardrecommendations
STC requirements (e.g. application focus,co-financing)
Assessment: material change triggers for program continuation (2/2)Relevance of strategic focus and technical soundness; and potential for impact in line with GF Strategy.
Epidemiological contextual updates
NSP revisions and updates
Investing to maximize impact towardsending the epidemics (noting choice of interventions,normative guidance, new technologies, etc.)
Effectiveness of implementation approaches
Funding landscape and STC
Ensuring RSSH & HRG in line with Strategy
Secretariat Assessment Applicant Assessment
TRP assesses the two sources of information and provides recommendations
High Impact or allocation > 400m (25 portfolios)
Focused: allocation < 75m (87 portfolios)
Core: allocation >75m < 400m (30 portfolios)
Portfolio Categorization
9
• Serbia• Solomon
Islands• Sri Lanka• Suriname• Tajikistan• Timor-Leste• Tunisia• Turkmenistan• Uzbekistan
• Angola
• Benin
• Burkina Faso
• Cameroon
• Congo
• Guatemala
• Lesotho
• Madagascar
• Namibia
• Nepal
• Papua New
Guinea
• Rwanda
• Senegal
• Swaziland
• Togo
• Bangladesh
• Cambodia
• Côte d'Ivoire
• Ethiopia
• Ghana
• India
• Indonesia
• Malawi
• Mozambique
• Myanmar
• Philippines
• South Africa
• Tanzania
• Thailand
• Uganda
• Viet Nam
• Zambia
• Zanzibar
• Zimbabwe
• QMU-M-
UNOPS (RAI)
• Albania• Algeria• Armenia• Azerbaijan• Belarus• Belize• Bhutan• Bolivia• Botswana• Bosnia and
Herzegovina• Bulgaria• Cape Verde• Colombia• Comoros• Costa Rica• Cuba• Djibouti
• Dominican Republic
• Ecuador• Egypt• El Salvador• Fiji• Gabon• Gambia• Georgia• Guyana• Honduras• Iran• Jamaica• Jordan• Kazakhstan• Korea, DPR• Kosovo• Kyrgyzstan
• Lao PDR• Macedonia
(FYR)• Malaysia• Mauritania• Mauritius• Moldova• Mongolia• Morocco• Nicaragua• Panama• Paraguay• Peru• Romania• Russian
Federation• Sao Tome and
Principe
• QMJ -C-UNDP• QMJ -M-UNDP• QMT-H-EHRN• QMZ-H-ECUO• QMZ-T-PAS• QPA -H-ANECCA• QPA -H-HIVOS• QPA -H-SADC• QPA -H-UNDP• QPA -M-E8S• QPA -T-ECSA• QPA -T-WHC• QPB -H-KANCO• QPF -H-ALCO• QRA -H-HIVOS• QRA -H-IOM• QSA -H-APN+• QSF -T-IOM
Multi/Regional
• Iraq• Palestine
• Syrian Arab Republic• Yemen • Congo, DR
• Kenya
• Nigeria
• Pakistan
• Sudan
• Afghanistan• Burundi• Central African
Republic• Chad• Eritrea• Guinea• Guinea -Bissau
• Haiti• Liberia• Mali• Niger• Sierra Leone• Somalia• South Sudan• Ukraine
COE
• MAR -H-SISCA• MAT -011 -G01 -H• MEA -011 -G01 -H• MEI -011 -G01 -H• MMM-011 -G01 -H• MSA -910-G02-H• QMG -M-PSI
Middle East Initiative
2017 -2019 Allocation methodology
10
ReplenishmentConference
Malaria(32%)
TB(18%)
HIV(50%)
Up to $800m
Up to $800m
Available sources of funds for allocation
Catalytic investments
Allocation formula using
disease burden and
country economic capacity
Formula derived
amounts
Transparent qualitative
adjustments
Communication of country
allocation with flexibility on
program split
Funding request +
application for catalytic investments
if eligible
ONGOING COUNTRY DIALOGUE
NATIONAL STRATEGIES
Eligibility for funding
11
• Eligibility is determined by a country’s income level and disease burden• The Global Fund Eligibility List identifies country components eligible to receive an allocation, however this does not
mean an allocation will be automatically awarded
Income level
Disease burden
Not eligible:• Upper-Middle income countries with low/moderate disease burden• G-20 Upper-Middle income countries with less than extreme disease burden• High income countries.
Low income countries
Lower -LMI countries
Upper-LMI countries Upper-Middle income countries
No restriction
No restriction
No restriction
Extreme, Severe or High
Extreme
This is a reprint of "Access to Funding" brochure by The Global Fund.
CONTACT LAC REGIONAL PLATFORMLatin America and the Caribbean Regional Platform for Support, Coordination and Communication of Civil Society and Communities
CRAT – VÍA LIBRE - International HIV/AIDS Alliance
Jirón Paraguay 490. Lima 1 – Peru.
www.plataformalac.org | facebook: www.facebook.com/plataformaLAC | Twitter: @plataformalac